Elizabeth B. Humphreys

8.1k total citations · 2 hit papers
100 papers, 6.2k citations indexed

About

Elizabeth B. Humphreys is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cancer Research. According to data from OpenAlex, Elizabeth B. Humphreys has authored 100 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Pulmonary and Respiratory Medicine, 16 papers in Surgery and 14 papers in Cancer Research. Recurrent topics in Elizabeth B. Humphreys's work include Prostate Cancer Diagnosis and Treatment (83 papers), Prostate Cancer Treatment and Research (82 papers) and Cancer, Lipids, and Metabolism (11 papers). Elizabeth B. Humphreys is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (83 papers), Prostate Cancer Treatment and Research (82 papers) and Cancer, Lipids, and Metabolism (11 papers). Elizabeth B. Humphreys collaborates with scholars based in United States, Canada and South Korea. Elizabeth B. Humphreys's co-authors include Alan W. Partin, Patrick C. Walsh, Leslie A. Mangold, Stephen J. Freedland, Misop Han, Mario A. Eisenberger, Bruce J. Trock, Frederick J. Dorey, Jonathan I. Epstein and William B. Isaacs and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Elizabeth B. Humphreys

98 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk of Prostate Cancer–Specific Mortality Following Biochemical Recurrence After Radical Prostatectomy

2005 1.0k citations Stephen J. Freedland, Elizabeth B. Humphreys et al. profile →
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer

2008 830 citations Rong Hu, Thomas A. Dunn et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth B. Humphreys United States	36	5.3k	1.3k	1.1k	980	969	100	6.2k
Leslie A. Mangold United States	37	4.5k 0.8×	934 0.7×	1.2k 1.1×	811 0.8×	1.0k 1.0×	91	5.8k
Charles R. Pound United States	24	5.1k 1.0×	837 0.7×	886 0.8×	644 0.7×	1.3k 1.3×	42	6.0k
Thomas Steuber Germany	42	5.1k 1.0×	1.3k 1.0×	1.3k 1.2×	1.0k 1.1×	1.4k 1.4×	210	6.5k
Alexander Haese Germany	57	7.3k 1.4×	1.7k 1.3×	1.6k 1.4×	1.1k 1.1×	2.0k 2.1×	261	9.2k
Mary Ellen Taplin United States	16	4.2k 0.8×	1.0k 0.8×	924 0.9×	1.6k 1.6×	274 0.3×	27	5.1k
Axel Semjonow Germany	35	2.6k 0.5×	746 0.6×	1.1k 1.0×	797 0.8×	503 0.5×	170	4.2k
Danny Vesprini Canada	35	2.5k 0.5×	998 0.8×	1.0k 1.0×	1.0k 1.0×	343 0.4×	159	4.9k
Hans Heinzer Germany	34	3.5k 0.7×	634 0.5×	752 0.7×	843 0.9×	910 0.9×	185	4.7k
Piet Ost Belgium	44	5.9k 1.1×	1.1k 0.9×	659 0.6×	1.7k 1.7×	688 0.7×	249	7.9k
Aude Fléchon France	33	4.9k 0.9×	1.5k 1.2×	1.8k 1.7×	2.6k 2.7×	276 0.3×	273	7.7k

Countries citing papers authored by Elizabeth B. Humphreys

Since Specialization

Citations

This map shows the geographic impact of Elizabeth B. Humphreys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth B. Humphreys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth B. Humphreys more than expected).

Fields of papers citing papers by Elizabeth B. Humphreys

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth B. Humphreys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth B. Humphreys. The network helps show where Elizabeth B. Humphreys may publish in the future.

Co-authorship network of co-authors of Elizabeth B. Humphreys

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth B. Humphreys. A scholar is included among the top collaborators of Elizabeth B. Humphreys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth B. Humphreys. Elizabeth B. Humphreys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jain, Alka, Eleanor M. Simonsick, E. Jeffrey Metter, et al.. (2019). Angiotensin receptor autoantibodies as exposures that modify disease progression: Cross sectional, longitudinal and in vitro studies of prostate cancer. SHILAP Revista de lepidopterología. 2. 100008–100008. 2 indexed citations

Ludwig, Wesley, Zhaoyong Feng, Bruce J. Trock, Elizabeth B. Humphreys, & Patrick C. Walsh. (2017). Prostate Specific Antigen Testing after Radical Prostatectomy—Can We Stop at 20 Years?. The Journal of Urology. 199(1). 114–119. 6 indexed citations

Youngstein, Taryn, Enrico Tombetti, Adil Al‐Nahhas, et al.. (2016). 18F-FDG uptake by prosthetic arterial grafts in large vessel vasculitis is not specific for active disease: results from a cohort study. Spiral (Imperial College London). 1 indexed citations

Jeong, Byong Chang, Heather J. Chalfin, Seung Bae Lee, et al.. (2014). The Relationship Between the Extent of Extraprostatic Extension and Survival Following Radical Prostatectomy. European Urology. 67(2). 342–346. 51 indexed citations

Sundi, Debasish, Ashley E. Ross, Elizabeth B. Humphreys, et al.. (2013). African American Men With Very Low–Risk Prostate Cancer Exhibit Adverse Oncologic Outcomes After Radical Prostatectomy: Should Active Surveillance Still Be an Option for Them?. Journal of Clinical Oncology. 31(24). 2991–2997. 176 indexed citations

Eifler, John B., et al.. (2012). Causes of Death After Radical Prostatectomy at a Large Tertiary Center. The Journal of Urology. 188(3). 798–802. 19 indexed citations

Lotan, Tamara L., Bora Gürel, Siobhan Sutcliffe, et al.. (2011). PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients. Clinical Cancer Research. 17(20). 6563–6573. 262 indexed citations

Magheli, Ahmed, Mark L. Gonzalgo, Li‐Ming Su, et al.. (2010). Impact of surgical technique (open vs laparoscopic vs robotic‐assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matching. British Journal of Urology. 107(12). 1956–1962. 80 indexed citations

Pierorazio, Phillip M., Elizabeth B. Humphreys, Patrick C. Walsh, Alan W. Partin, & Misop Han. (2010). Radical prostatectomy in older men: survival outcomes in septuagenarians and octogenarians. British Journal of Urology. 106(6). 791–795. 26 indexed citations

10.

Hernandez, David J., Misop Han, Elizabeth B. Humphreys, et al.. (2009). Predicting the outcome of prostate biopsy: comparison of a novel logistic regression‐based model, the prostate cancer risk calculator, and prostate‐specific antigen level alone. British Journal of Urology. 103(5). 609–614. 35 indexed citations

11.

Isharwal, Sumit, Michael Craig Miller, Jonathan I. Epstein, et al.. (2009). DNA Ploidy as Surrogate for Biopsy Gleason Score for Preoperative Organ Versus Nonorgan-confined Prostate Cancer Prediction. Urology. 73(5). 1092–1097. 12 indexed citations

12.

Loeb, Stacy, Edward M. Schaeffer, Bruce J. Trock, et al.. (2009). What Are the Outcomes of Radical Prostatectomy for High-risk Prostate Cancer?. Urology. 76(3). 710–714. 101 indexed citations

13.

Isharwal, Sumit, Michael Craig Miller, Jonathan I. Epstein, et al.. (2008). Prognostic value of Her‐2/neu and DNA index for progression, metastasis and prostate cancer‐specific death in men with long‐term follow‐up after radical prostatectomy. International Journal of Cancer. 123(11). 2636–2643. 21 indexed citations

14.

Veltri, Robert W., Sumit Isharwal, Michael Craig Miller, et al.. (2008). Long‐Term assessment of prostate cancer progression free survival: Evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis. The Prostate. 68(16). 1806–1815. 31 indexed citations

15.

Hu, Rong, Thomas A. Dunn, Shuanzeng Wei, et al.. (2008). Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer. Cancer Research. 69(1). 16–22. 830 indexed citations breakdown →

16.

Makarov, Danil V., Stacy Loeb, Ahmed Magheli, et al.. (2008). SIGNIFICANCE OF PREOPERATIVE PSA VELOCITY (PSAV) IN MEN WITH LOW SERUM PSA AND NORMAL DRE. The Journal of Urology. 179(4S). 721–722. 1 indexed citations

17.

Alumkal, Joshi J., Zhe Zhang, Elizabeth B. Humphreys, et al.. (2008). Effect of DNA Methylation on Identification of Aggressive Prostate Cancer. Urology. 72(6). 1234–1239. 44 indexed citations

18.

Freedland, Stephen J., Elizabeth B. Humphreys, Leslie A. Mangold, et al.. (2007). Death in Patients With Recurrent Prostate Cancer After Radical Prostatectomy: Prostate-Specific Antigen Doubling Time Subgroups and Their Associated Contributions to All-Cause Mortality. Journal of Clinical Oncology. 25(13). 1765–1771. 150 indexed citations

19.

Freedland, Stephen J., Alan W. Partin, Elizabeth B. Humphreys, Leslie A. Mangold, & Patrick C. Walsh. (2007). Radical prostatectomy for clinical stage T3a disease. Cancer. 109(7). 1273–1278. 107 indexed citations

20.

Partin, Alan W., Mario A. Eisenberger, Victoria J. Sinibaldi, et al.. (2004). Prostate specific antigen doubling time (PSADT) predicts for distant failure and prostate cancer specific survival (PCSS) in men with biochemical relapse after radical prostatectomy (RP). Journal of Clinical Oncology. 22(14_suppl). 4555–4555. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact